Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
GenBio Inc. Advances Intellectual Property Strategy Following Review of New Scientific Data
EIN Presswire
Senior scientific and intellectual property review evaluates emerging research findings and potential opportunities to strengthen and expand GenBio’s portfolio ALISO VIEJO, CA, UNITED STATES, August 17, 2026 /EINPresswire.com/ -- GenBio Inc....
Green Ninja Redesigns Middle School Science Units to Make Rigorous NGSS Learning More Accessible
GlobeNewswire, Inc.
SAN JOSE, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- As schools start the 2026–27 school year, Green Ninja has officially released seven redesigned New Generation Science Units for grades 6–8. The units were developed in response to a significant...
Aloe Arborescens Announces New Initiatives Within Its Ongoing Botanical Formulation Research Program
EIN Presswire
Aloe Arborescens expands research on aloe-derived compounds, formulation consistency, compositional analysis, and nutritional science evaluation.
At 80, Air Force Veteran and Former FAA Inspector Bryan Neville Has Written Six Books—and Shows No Signs of Stopping
EIN Presswire
The ATP-rated pilot draws on years of aviation, military service, faith, and experience to write science fiction, political thrillers, and practical nonfiction.
Locus Technologies Launches EU Refrigerant Management Software to Help Organizations Meet EU F-Gas Requirements
GlobeNewswire, Inc.
MOUNTAIN VIEW, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Locus Technologies, the leader in science-grade environmental information management and EHS compliance software, today announced the launch of the European Union version of its Locus...
Low-Passage Mesenchymal Stem Cells from Cloud-Clone Empower Global Scientific Research
EIN Presswire
Cloud-Clone Low-Passage MSCs Power Full Pipeline for Degenerative Disease Research & Novel Cell Therapeutics HUSTON, TX, UNITED STATES, August 17, 2026 /EINPresswire.com/ -- Against the backdrop of rapid advances in life sciences and cell-based...
PyroGenesis Announces $1.4 Million Contract to Supply Two Plasma Torches to European Mining, Metallurgy & Materials Entity
GlobeNewswire, Inc.
MONTREAL, Aug. 19, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to...
Applied Biologics Welcomes CMS’ Continued Commitment to Clinical Evidence in Advanced Wound Care
GlobeNewswire, Inc.
SCOTTSDALE, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today welcomed the Centers for Medicare & Medicaid...
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®
GlobeNewswire, Inc.
- Complementary peptide-mapping methods increased coverage of the active botulinum neurotoxin primary sequence from approximately 93% to 98%, with 100% amino acid identity across all regions analyzed - Preliminary analysis demonstrates...
Avicanna Announces Closing of Strategic Non-Brokered Private Placement
GlobeNewswire, Inc.
TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived...
CBB 2026: Global Liquid Food Industry Chain Event to Open in Shanghai This October
GlobeNewswire, Inc.
SHANGHAI, Aug. 19, 2026 (GLOBE NEWSWIRE) -- As a benchmark whole-industry-chain event for the liquid food industry in Asia, this year's exhibition will be held grandly from October 12 to 15, 2026, at the Shanghai New International Expo Centre...
Nasus Pharma Announces Transition of Chief Financial Officer
GlobeNewswire, Inc.
TEL AVIV, Israel, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE American: NSRX) ("Nasus", “Nasus Pharma” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today...
Atsena Therapeutics Appoints Matt Pauls to Board of Directors
GlobeNewswire, Inc.
Matt Pauls brings more than 25 years of biopharma leadership and rare disease clinical development and commercial expertise as Atsena advances its ocular gene therapy pipeline toward commercialization DURHAM, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE)...
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
GlobeNewswire, Inc.
August 19, 2026 Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP 87 subjects, over 50% of target, recruited Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “the Company”), a clinical stage...
Columbus Crew and Scotts Host Ohio 4-H Youth for First-ever Mowing Clinic at ScottsMiracle-Gro Field
GlobeNewswire, Inc.
COLUMBUS, Ohio, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Ohio 4-H youth were treated to a unique, hands-on immersion into the world of turfgrass science and management during an exclusive Mowing Clinic hosted by the Columbus Crew and Scotts.
Smartkem, Inc. announces reverse split of common stock to support continued Nasdaq listing
GlobeNewswire, Inc.
WILMINGTON, Del., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Smartkem, Inc. (Nasdaq: SMTK) ("Smartkem" or the "Company") today announced that its Board of Directors has approved a reverse stock split of the Company’s outstanding common stock at a ratio of...
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
GlobeNewswire, Inc.
Highest Q2 and H1 revenue in Company history, reflecting strength across all core segments and reaching a new milestone with an adjusted annualized revenue run-rate exceeding $75 million Continued progress toward profitability targets, with...
Kynexis Extends Series A to €97 Million to Advance Potential First-in-Class Investigational Medicine for Cognitive Disorders
GlobeNewswire, Inc.
Novartis Venture Fund joins Kynexis’ existing investor syndicate, supporting the Company’s vision of becoming a leading late-stage cognition company Financing supports Phase 2 close-out activities and preparation for registrational studies of...
VOKA receives Bronze Award at the National Health Information Awards 2026
EIN Presswire
This prestigious win highlights VOKA’s commitment to delivering world-class, scientifically accurate 3D medical content.
UW-Superior exercise science program now a stand-alone major
University of Wisconsin System
Campus Stories The University of Wisconsin–Superior’s Bachelor of Science in exercise science has been elevated from a concentration to a stand-alone major, enhancing the program’s visibility and providing clearer recognition of students’...
Sign up for:
Science Times Observer
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.